BMY vs INVX · P/E 17, rev $24.46B vs P/E 8.0, rev $483.9M
Bristol-Myers Squibb Company (BMY) versus Innovex International, Inc (INVX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Innovex International, Inc (INVX) is a oil & gas equipment & services company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported INVX revenue for 2026-06-30 was $483.9M. Net income was $8.4M. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
Not investment advice. Open the BMY and INVX stock pages for the full models.
Not investment advice.